Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Possible Effects of Roflumilast on Obesity Related Disorders

NCT04800172 is registered in ClinicalTrials.gov with Tanta University as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04800172 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Possible Effects of Roflumilast on Obesity Related Disorders
Lead sponsor
Tanta University
Phase
Phase 3
Overall status
Completed
Start date
May 1, 2021
Completion date
March 31, 2022
Enrollment
66 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

obesity, prediabetes